This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Taylor Cohen - Innovator in Antibody Research
Introduction
Taylor Cohen is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target the spike protein of SARS-CoV-2. His innovative work has implications for the treatment and prevention of COVID-19.
Latest Patents
Taylor Cohen holds a patent for "Antibodies That Bind the Spike Protein of SARS-CoV-2." This patent represents a crucial advancement in the fight against the pandemic, showcasing his expertise and dedication to scientific research. He has 1 patent to his name.
Career Highlights
Cohen is currently employed at AstraZeneca U.K. Limited, where he continues to work on groundbreaking research in the field of immunology. His role at AstraZeneca allows him to collaborate with leading scientists and contribute to the development of life-saving therapies.
Collaborations
Throughout his career, Taylor has worked alongside notable colleagues, including Joe Francica and Gilad Kaplan. These collaborations have fostered a dynamic research environment, enhancing the potential for innovative discoveries.
Conclusion
Taylor Cohen's contributions to antibody research exemplify the impact of innovation in addressing global health challenges. His work at AstraZeneca and his patent on SARS-CoV-2 antibodies highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile